News / 05.05.2020

Icare USA Launches Two New Next Generation Imaging and Tonometry Devices:

Icare USA Launches Two Devices: The CenterVue DRSplus Confocal Fundus Imaging System and Next-Generation Icare ic200 Handheld Tonometer
The DRSplus sets a new standard for retinal imaging, while the Icare ic200 makes portable glaucoma testing even easier.

RALEIGH, NC, May 5, 2020—Icare USA today announced the release of two exciting new diagnostic technologies: the Centervue DRSplus confocal fundus imaging system, the new effective and efficient standard in retinal imaging, and the Icare ic200 handheld tonometer for portable measurement of intraocular pressure (IOP).

“We’re excited to introduce clinicians to these new technologies – the disruptive DRSplus platform and the next-generation Icare ic200,” said Icare CEO John Floyd. “With last month’s merger of Icare and CenterVue under the Revenio Group, we are steadfast in our pursuit of exceptional diagnostic technologies for both the glaucoma and retina specialties. These two devices certainly embody that mission.”

The DRSplus confocal fundus imaging system uses white LED illumination, which includes the entire visible spectrum, to produce TrueColor and detail-rich images, setting a new standard for retinal imaging. Compared to traditional fundus camera imaging, DRSplus images are sharper, with better optical resolution and greater contrast, even through cataracts. Physicians can view detailed 45° retinal images as well as panoramic 80° images using the Mosaic function. Fast, fully automated operation speeds up exam time and requires minimal training.

Atul Jain, MD, of Retinal Specialists San Diego stated, “The DRSplus is a revolutionary retinal imaging camera that truly provides outstanding diagnostic caliber, non-mydriatic color fundus photographs that exceed the expectations of even the most particular of retina specialists. Furthermore, its ease of use and ability to reproduce consistently high-quality color images of both eyes in under 10 seconds, with the push of a single button, makes it an invaluable staple in any clinic requiring assessment of macular diseases and pathology. This technology has the power to replace traditional slit lamp biomicroscopy in the majority of retinal patients, allowing the physician more time to discuss important findings with the patient as well as documenting relevant pathology. Our staff finds the system’s fully automated capabilities and optimized patient comfort enhance efficiency and workflow. And that’s just the tip of the iceberg – the ability to be viewed from anywhere and integrate seamlessly into virtually all EMR platforms, makes the DRSplus a wise choice for clinical needs.”

“Throughout my years in practice, I’ve welcomed the addition of several traditional fundus imaging techniques to my clinical protocols, however, image detail was affected by pupils smaller than 3 mm and by any visually significant media opacities”, said John Warren, OD, private practitioner in Racine, Wisconsin. “Because the DRSplus is a TrueColor confocal imaging tool, the quality of images isn’t nearly as affected by pupil size or opacities such as cataracts. Even pupils as small as 2.5mm are rarely a problem with the DRSplus, nor are moderate to slightly worse cataracts a significant hindrance. I now utilize the DRSplus as the primary means of fundus examination for the majority of my patients, including those with age-related macular degeneration, diabetic retinopathy, glaucoma, and epiretinal membrane. This has greatly improved both the quality and efficiency of my patient encounters, while optimizing patient comfort.”

The Icare ic200 is the next generation in Icare’s trusted handheld tonometer line. Based on a rebound measuring principle, the device measures IOP without any anesthetic drops, air puffs or specialized skills. Enhancements to the ic200 include the ability to test patients while they are sitting, supine or elevated. A new streamlined design and user interface include light indicators that confirm the tonometer is positioned properly for measurement.

Philip Ngai, MD, glaucoma specialist at San Gabriel Valley Eye Group, commented, “The ic200 is an incredible machine that has improved the workflow of our practice, and allowed us to provide better care for our glaucoma patients. In particular, this device allows us to measure IOP in eyes that were traditionally very difficult, or sometimes even impossible to measure with other tonometry methods. Most importantly, its measurements are accurate and reliable when compared to applanation. The device itself is portable and can obtain measurements quickly and painlessly with very little training. Our patients are thrilled with the device, and so is our staff. As our practice grows, we will not hesitate to obtain more ic200s in the future.”

About Icare and Revenio Group
As part of Revenio Group Corporation, a health technology group operating in the international markets and a global leader in ophthalmic appliances, Icare is joined by CenterVue, Revenio Research and Oscare Medical. All of these business operations excel in developing efficient and easily adopted methods for early-stage detection of diseases with significance for public health. For more information, visit www.icare-usa.com, www.centervue.com, or www.reveniogroup.fi/en.

Company Contact:
John Floyd, CEO
(888) 422-7313
john.floyd@icare-usa.com